+924.9%
MRNA vs LYV
+26.7%
+898.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LYV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -1.1% | -5.5% | -5.6% |
| 7D | +8.4% | +1.9% | +6.5% | +7.0% |
| 30D | +28.8% | +5.5% | +23.3% | +23.7% |
| 3M | +329.2% | -1.2% | +330.5% | +336.1% |
| 6M | +416.9% | +15.3% | +401.7% | +412.2% |
| YTD | +718.8% | +27.2% | +691.6% | +703.9% |
| 1Y | +924.9% | +34.5% | +890.4% | +867.8% |
| All | +924.9% | +26.7% | +898.1% | +867.8% |
Cumulative growth
Daily Returns
Daily percentage return beside LYV.
Daily Out/Under-Performance
Portfolio return minus LYV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LYV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LYV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling